Posted by Michael Wonder on 20 Jul 2023
DUSC utilisation analysis public release documents (February 2023)
20 July 2023 - The utilisation analysis public release documents from the February 2023 DUSC meeting are now available.
There is actually only one public release document - evolocumab for hypercholesterolaemia.
